Simcoe Capital Management Picked Up Exar Corp (NYSE:EXAR) Shares

In a just published Form 13, filed with the US Securities and Exchange Commission (SEC),...
Stay Ahead of the
Stock Market Game!
Subscribe to Small Cap
Exclusive for more


Guess Who Just Picked Up Ocular Therapeutix Inc. (NA...
New IPO Stock Therapix BioSciences (NASDAQ:TRPX) Is ...
Here's Who Just Picked Up Natera Inc. (NASDAQ:NTRA) ...

In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Exar Corp (NYSE:EXAR) reported that Simcoe Capital Management has picked up 2,577,901 of common stock as of 2017-03-30.

The acquisition brings the aggregate amount owned by Simcoe Capital Management to a total of 2,577,901 representing a 5.0% stake in the company.

For those not familiar with the company, Exar Corporation (Exar) designs, develops and markets analog mixed-signal integrated circuits (ICs) and sub-system solutions. The Company’s products are deployed in a range of applications, such as industrial, instrumentation and medical equipment, networking and telecommunication systems, servers, enterprise storage systems, flat panel displays, light emitting diode (LED) lighting solutions, set top boxes and digital video recorders. Exar’s product portfolio includes connectivity, power management, high performance analog, communications, processors, flat panel display and LED lighting. The Company designs and develops amplifiers and data converters that support a range of signal path and conditioning needs of networking, industrial control and embedded applications. The Company markets its products to three primary markets, such as industrial and embedded systems, consumer and infrastructure.

A glance at Exar Corp (NYSE:EXAR)’s key stats reveals a current market capitalization of 807.97 Million based on 50.89 Million shares outstanding and a price at last close of $12.98 per share.

Looking at insider activity, there are a few transactions worth noting.

Specifically, on 2016-08-08, Lougheed picked up 3,000 at a purchase price of $8.81. This brings their total holding to 32,471 as of the date of the filing.

On the sell side, the most recent transaction saw Guilbault unload 6,500 shares at a sale price of $9.76. This brings their total holding to 42,500.

It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Exar Corp (NYSE:EXAR) as things move forward to see if its progress aligns with these transactions.

Subscribe below and we’ll keep you on top of what’s happening before it moves markets.





Stay in the lopp :

Pluristem Therapeutics PSTI Collaboration

Pluristem Therapeutics PSTI signs a massive collaboration deal. Also, the stock looks great. Take a look below.

Guess Who Picked Up Issuer Direct Corp (NYSEM...
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Issuer Direct Corp (NYSEMKT:ISDR) reported that Red Oak Partners, Llc.
ESPR Esperion Therapeutics, Inc. Consolidatio...

(NASDAQ:ESPR) Esperion Therapeutics Inc

  (NASDAQ:ESPR) Esperion Therapeutics, Inc. peaked out and closed at $48.90, way up from about $10 where it sat last August, but way

related post

Skip to content